ATLANTA, Jan. 14, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Pacira BioSciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX). The lawsuit alleges that Defendants created the false impression that Pacira had sufficient patent protections on Exparel, and as such, the ability to expand the marketing, production, and sales of Exparel. The lawsuit alleges that Pacira knew that the ‘495 patent was not as protective as Defendants publicly touted. If you bought shares of ...